Kathryn Ibata-Arens

In a fast-paced high-growth economy – picture any big city in Asia – urban professionals are under pressure to “get back to work” even when they feel ill. The resulting demand for “fast-fix” remedies could lead to over-prescription and societal ills. Opioid abuse that is plaguing the United States and other Western countries could well become a major problem in Asia. Governments and pharmaceutical companies in the region should continue to focus on driving innovation in the development of treatments and resist the temptation to pursue the easy profits of the lifestyle-drug approach, Kathryn Ibata-Arens from DePaul University writes.